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INTRODUCTION 
Mechanism of Action ·I 
Steroid hormone receptors are soluble proteins ~hich 
probably play a key role in the mech~riism of action oflthe 
! 
steroid hormones. The presence of recept9r appears to be 
prerequisite for cellular response to changes in·hormopal 
milieu (1), The mechanism of action of steroids with their 
target cel·ls is shown in Figure. Unbound steroid enters 
' the cell by passive diffusion and combines with cytopl~smic 
I 
recepto~ in an association characterized by high affinity 
and ligand specificity (2). In the case of estradiol," it 
' 
has been _proposed that binding occurs ont·o a 4 S ·binding 
(Yf0f/A5M 
RNA.-----,~--...._ 






---~IJ.~'f_1A_~_E-. S· R fiANSIOllMAT!OV S· R' TIAN!ilOCAfiON 
(- C 'AC fl VAT/ON. C 
s 
Proposed Steps in Steroid Hormone /Target c
1
6ll 
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the cytoplasmi~ receptor.as Re, and the nuplear 




4 S binding subunit of the 8 S receptor followed by a 
temperature dependent 4 S. to 5 S transformation and subsequent 
translocation to the nucleus (3). The nuclear hormone' 
receptor complex then associates with chroma t.in resul t~ng in 
stimulation of messenger RNA synthe~is and the subsequlnt 
I 
formation of cellular proteins (4). The nature of the' 
departure and fate of the nuclear hormone recep·tor complex 
is unknown (1). dellular replication and differentiat~on 
appear to result from this cascade of events, when in t!act 
i 
( 5) • 
I 
Normal breast contains specifi·c bin'ding sites for 
I 
estrogens, progestins, corticoids, and androgens, prolactin, 
growth hor·mone, and insulin (6). Estrogen and prolactin are 
the two primary hormones in breast growth regulation (i7). A 
I 
I 
model of complete endocrine regulation of breast tisstje must 




' The concept underlying endocrine therapy .is that certain 
tumor cells ;etain the ability to respond to the samelhormonal 
I 
perturbations as their normal progenitors .(l)·. That :j_s, 
i 
certain cancer cells are dependent on one or more hormones 
and suc·cumb when deprived of supporting hormones or when 
pharmacologic levels of hormone ar.e .administered (8) ·1 
Human and experimental breast tumors which regress 
I . 
following_endocrine therapy frequently contain a cytopJasmic 
protein that specifically binds estiadiol with high ~ffirtity ·(9). 
3 
·i 
It is assumed that the presence of estrogen receptor (ER) in 
breas.t tumor. is due to the expression of a phenotypic 
characteristic of the norma~, hormonally responsive cell line 
I 
of: origin (1). Cells which have undergone malignant 
transformation may retain all or only part of the normal 
I 
I 
receptor population, and, in theory at least, hormonaljcontrol 
I 
should be absent in.the absence of specific receptor (8). 
The observation, as previously noted, that labelkd . . . I . 
estrogens are localized in highest concentrations fn e!strogen 
target orgtns, led to the suggestion-by .J~nsen et· al. ln 
1965 that the ability of breast tumor to bind estrogen might 
be predictive of responsive to endocrine therapy (10). This 
idea was supported by their later findings i.n which th'e 
I 
I 
. presence of estrogen receptor in tumor biopsies correl!ated 
. I 
I 
.with favorable r·esponse to adren;i.lectomy (11) and by ·t;he 
. I 
observation of Fo:t.ca et al. (12) that when tritiated liexestrol . ' 
I . 
was administered .to breast cancer patients prior to adrenalectomy, . . ·I . . . . 
metastases which subs_equently regressed concentrated a larger· 
I : 
I 
fraction of the labeled estrogen than those which failed to 
·I 
respond. A correlation between the presence of estrogen 
I . 
receptor in breast tumor biopsy_ material and favorable response 
to endocrine therapy was presently confirmed in.the llborator~es 
of Wittli{f (13) and McGuire (14). 
Endocrine additive and ablative therapies are ihterventions 
are 'without potentially serious· complications. Meth_o
1
1ds of' ' 
ac.curate selectiori could spare critically i11 patients in whom - I 
endocrine therapy is unlikely to succeed from unnecessary 
treatment. An expansion of steroid binding data has followed 
to the pres~nt, and, while it remains true 
receptor negative tumors rarely respond to 
that estroglen 
endocrine therapy, 
the response of ER positive tumors varies :over a wide range (15). 
It is now generally accepted that selection of patien~s by 
' 
estrogen receptor analysis improves the response rate :to 
endocrine.therapy by at least two-fold over non-selected cases 
I 
( 2) • It has also been.suggested that ER negative tumors tend 
' 
to have higher mitotic iates as estimated by thymidin~ labeling, 
and that these more rapidly growing tumors might be 
' :! 





Specific receptor for progesterone has also been identified 
in breast tumor cytosols (17). 
I 
Improved response ·.rates to 
endocrine therapy in ER positive tumors has been reported· if 
I 
I 
specifiti progesterone receptor (PR) is also present (18).. It 
I 
has· been demonstrated that following oophorectomy, cyfosol 
progesterone retieptor levels diminish while cytosol Ef levels. 
I remain high (19). As the synthesis of progesterone receptor 
, I 
may be estrogen dependent, Heusen et al. has suggested that 
PR positivitj might simply be a reflection of ER conclntra~ion. 
This conc.ept is complicated by the ·puzzlin~ obsio:rvatilbn that 
tumors which are ER negative but PR positive (an enigma in 
I 
theory) often respc°ns to endocrine manipulation (20).' It is 
currently accepted that steroid receptor analysis in mammary 
carcinoma 
therapy, 
allows. for prediction .of response to endocline 
and that the rate of response ts highest when both 
5 
ER and PR are present (21). 
Failure to Respond 
Many tumors which contain specific estrogen 
proteins do not respond to endocrine maneuvers. The ca:paci ty· 
' 
to bind estrogen, therefore, does not obligate a biological 
response to the hormone. Events beyond the level of b~nding to 
receptor may be defective, such as receptor transforma~ion 
! 
( 4 S - 5 S), translocation to the nucleus, and binding into 
chromatin. 
Thus, given the multiple subunit model shown in Figure 1, 
' I 
c~rtain.unresponsive breast cancers could contain specific 
estrogen binding protein, but .not the full. complement of 
. . I 
I 
receptor sutiunits necessary for transforamtion and trahslocation 
(2). This may also explain, at least in part, the imp~oved 
I 
response rates of tumors when.both ER and PR are present. The 
- I 
response of progesterone receptor, ·assuming the .dependence of 
PR synthesis on estrogen stimulation, V>'.Ould rule out a defect 
I 
in estrogen interaction beyond the level.of binding to receptor 
( 22). 
Another factor which may enter into the failure.of 
receptor positive tumors to respond to endo.crine mai1ibul·a tion 
I . 
is the heterogeneity of tumors with regard to cellular 
composition. While.the receptor concentration by ass~y 
represents .an i.ntegrated value for the entire biopsy,, the actual 
concentration of receotpr may vary widely from cell tp cell. 
! 
I 
Tumor biopsies wh.ich are receptor· (R) positive are l.iJkely to 
: 
6 
include a variable number of receptor negative cells. It may 
I ' 
be that hormone dependent cells atrophy as a result of milieu 
alterations, while hormone independent cells continue to 
proliferate. This theory is 
that in tumors which regres_s 
complicated by the observation 
I 
following oophorectomy a?d then 
·1 
resume growth (obstensibly due to proliferation of the hormone 
! 
independent sub-population). a second remission can be: induced: 
i 
. . ! 
by further ablative therapy such as adrenalectomy or ~ypo-
1 
I 
physectomy. A possible explanation for ·this phenomenon is 
. i 
! . 
that regrow.th included both receptor positive and receptor 
I 
I 
negative cells, with periphera~ conversion of androstenedione 
. . I 
to estrone allowing R positive cells to_ participate. I Adrenal-
ectomy or hypophysectomy would eliminate the adrenal source 
. I 
. . . I 
of estrogen precursors, allowing for the second regr~ssion 
I 
of R positive cells. In reality, t1.1mor cell subpopullations 
may represent a continuum of varying receptor populatlions in 
varying concentrations, and different endocrine therJpies may 
be affecting different levels of endocrine reguiatio~. There 
I 
is no apparent correlation between tumor histology and hormone 
I 
binding·capacity (1, 2, 6). I 
Carci.nogenesis I 
It is established that 'the mammary gland is sensitive 
to the .actions of carcinog-ens and is a major site 'fat the 
concentration of dimethylbenz (a) - anthracene (DMBA) and 
trimethylbeilz (a) anthracene (TMBA) (23). Both 1·, J2, DMBA 
· · · 11 · I. ct b and 7, 8, 12 TMBA are highly carcinogenic, c aracterize y 
:;;, 
7 
multiplicity of tumors and rapi.di ty of carcinogenesis. 
Carcinogenicity of aromatic hydrocarbons is associated! with 
·their ability to form charge transfer complexes with local 
I 
I 
acceptors and donate an electron. There is also a dirrct 
increase in carcinogenicity as hydrocarbons become sterically 
similar to steroids. There is a remarkable steric similarity 
I 
I . 
between carcinogenic polynuclear aromatic hydrocarbon~, growth 
promoting steroids, and.nucl'eic acid base pairs. 
Specific receptors for estrogen and profesterone have 
I 
been demonstrated in DMBA induced tumors (24). Receptor of 
DMBA induced tumors-behaves like that of human mammary tumors 
' with regard to range of concentrations, affinity (Kd)l and· 
molecular species by gradient centr.ifugation ( 6). 
rep.orted that among tumors induced b.Y DMBA in rats 
Sprague-Dawley strain, 85-90% are estrogen receptor 
and 85% are progesterone receptor positive (25). 





DMBA induced carcinoma of the rat shares a numbbr of 
. I 
characteristics with human breast cancer, as well as some . . 
differences.·' The common characteristics in biologicaO. 
I 
behavior and response of cytostatic and endocrine the~apy· 
make chemically induced rat mammary carcinoma a· sui tabl.e 
model for human breast cancer (26). In this in~estigation, 
I 
I 
cytoplasmic and nuclear binding sites for estrogen atjd 
progesterone in DMBA induced 
by titration assay. Results 
mammary carcinomas were innalyzed 
were compared between t,o groups 
of tumors categorized by response to oophorectomy. 







following oophorectomy. In the second gr.oup, termed hormone 
independent, tumors continued to grow. It is the purpose of 
~· . I 
this study to examine the differences in steroid bind:i'ng 
parameters between these two biologically defined tumo,r 
populations. 
Ml\TEIUALS il'"D ME'I'l!ODS 
l\nimai Treatment ' 
-·----·-~:mature> female rats of the Sprague-Dawley strlin 
I . 
were obtained from Harl.an Industries, Indianapolis,! Ind., 
housed .in temperature- and light-controlled quarter's, and 
su1.mli"'d with water and Purina Laboratory Chow (R-alston 
Purina Co., St. Louis, Mo.) ad libi tum. 
I 
At age 50 ± l days, under light ether anesthe~ia, 
animals were administered a single feeding of 20 milli-
qrams of 7,12 dimethylbenz(a) anthracene. (DMBA), in 2 
Milliliters of oil emulsion, by intra-gastric 
' 
Beg-inning at one month after DMBA treatment, ~nimals 
W<>re palpated once a week· for the appearanc.e of mairunary 
tumors. When the average diameter of a palpable tumor 
I 
exceeded 2 cm., the animal was anesthetized with I 
! 
pentabarbital•(the Butler Co., Columbus, 0.) at a ~ose 
• 
of 3 - 4 mg per 100 g body weight intraperitoneall~, and 
I 
subjected to bilateral oophorectomy. At the time ;of 
surgery, tumors w.ere measured with ca 1 ipers and mdpped. 
Approximately 1/2 of th~ tumor was removed for redeptor 
analysis, leaving 1/2 part in the host for observation 
of i~s growth pattern. 






tissue and_debris, ~rozen on dry .ice/acetone and stored 
i 
at -20° C. 
I 
Hormone Dependence 
If following oophorectomy, a tumor regressed 
completely it was termed hormone-dependent, and if,it 
continued to gro'w it was termed'hormone-independent, the 
period of observation being one month. For the hormone 
! 
dependent group, biopsy material obtained at oopho~ectomy 
was utilized for receptor analysis.· For the hormone 
independent group, animals bearing tumors wh'ich cortinued 
to grow following oophorectomy were stunned and decapf-
tated ~nd tumor tissue was removed and processed as· 
described for tissues obtained at oophorectomy. 
Reagents 
For binding experiments [2,3,4,5,16,17- 3H] e~tradiol 
' 3 
- 17 beta (151 ci/mmol); (17 oc m·ethyl - H] R5020, (17,21 




R5020 were obtained from New England 
Unlabeled diethylstibestrol (DES), )Tris 
preset crystals '(pH 7.0 at 21° C), and n,n-dimeth~l 
I 
I 
formamide were purchased from Sigma Chemical Co. 
ScintiVerse E was purchased from Fischer Scientif~c, and 
Analytical grade hydroxylapatite (DNA grade HTP) 
was purchased from BioRad. 
11 
I?~~ermination of Cyto~~-1 __ <_!-E~ .. <!_ Nuclear Binding Sites_ 
Binding site deturm1nations employed and modifica-
tions of the hydroxylap::it.i te methods of Chamness e~ al 
I 
and Pavlik and Coulson (27, _281. All p;ocedures.w,re 
C ' ~. d t . f . t d t 0 - 4 ° .c' 11 ,,r.1P ou on ice or r<· riC)era··e . a un .ess 
otherwise specified. 
Frozen tissue was weighed, minced on a coid glass 
pl..;te and homogenized in buffer containing 10 mM Tris 
0 (pH 7.56 at 0 ) and 7 1/2 percent n,n dimethylformamide· 
( v /v) . Homogenizations were carried out in a seven 
millilitet ~enBroeck pyrex glass-glass tissue grinder 
at a ratio of approximately 100 "mg tissue per ml b,uffer. 
The homogenate was centrifuged· 10 minutes at 800 x g. 
The supernatant was further centrifuged for 50 minutes 
' . ; 
at 45, 000 ·x g to yield the high speed supernatant, 
I 
(cytosol). The first pellet was resuspended in homo-
I 
genization buffer and washed twice by centrifugation for 
• 
10 minutes at.BOO x g discarding the supernatants; ·then 
resusp~nded for one hour in homogeni~ation bufferlcon-
. I 
taining 0.4 M potassium chloride for extraction of 
. I 
nuclear receptors. The pellet suspension was then 
centrifuged for 10 minutes at 3000 x g and fhe super-
natant (nuclear extract) was assayed 
rPceptors. 





Fiv_e hundred microl i tcr aliqu•)tS of cytosol or 
nuclc•ar extract were incubated with four I final concen-
1 
lratfons of either [
3
HJ .estradiol - 17 Beta ( . 15' ~ 5' 
3 . 0 ' l 0 . 0 nM) ~ r r 3 H I R 5 0 2 0 ( . 5 ' :J • 0 ' 15 . 0 ' 4 5 nM) i· in 
. I 
h<WlO•Jcnization buffer. Reactions were performed in 
parallel with a 200 - fold ex~ess of radioinert corn~ 
.• ·- I 
1o<·t:itor for determi·nation of non-specific binding·.' DES 
was used in estrogen receptor assays and unlabeled 
R5020 was used in progesterone receptor assays. 
Incubations were for 16-18 hours at 0 - 4° C. ·The 
synthetic progestin R5020 is especially useful in , 
I 
n,cc.ptor studies because it does not !:!ind to corti'co-
st.-·roid binding globulin (C'BG) (17-). Similarly, an 
important advantage of DES (a non-steroidal estrogen) is 
I 
its low affinity for sex steroid ·binding globulin !(SSBG) 
(29). 
~IX~.1:.£~Y lapati te (HAP) 
At the ~nd of incubation duplicate 200 microliter .• 
a.liquots fr6m each incubation tube were added to ~ubes 
containing ona milliliter of 101 hydroxylapatite ~lurry 
( prE'pa n•d by suspending 10 grams ·of DNA grade BioGel JITP 
. . I . 
homogenization buffer). Adsorption to HAP in 100 ml of 
wa~ carried out for 45 minutes, with occasional vortex 




I . . . 




was washed three times with 2 ml homogenization buffPr 
' 
by centrifugation for 2 minutes at 800 x g, discard~n<J 
I 
the supernatants. 
Hound radioactive steroid was removed from HTP/by 
extraction into .1. 5 ml 100'1; ethanol ( 30 minutes, rnorn 
tenverature), and then counted in 5 ml of scintillation 
' 
fluid (ScintiVerse E, Fischer Scientific). All counts 
. ! 
were made in Packard TriCarb Model 300 Liquid 
Scintillation Spectrometer at· Maxey Flats Low-Leve~ 
Nuc1ear Waste Disposal Site. 
For the calculation of binding capacity ( B .· )i max. and 
affinity (dissociation constant, Kd), data .were plolted 
according to the· method of Scatchard (46) and subjected 
to least squares regression analysis. Table 1 andi· 
Figure 2 depict representative titration data and : 
I 
I 
Scatchard analysis. Total bound steroid (BT) is the 
amount of radioactive steroid bound 
competito~. Non-specifically bound 
in the absence/ 
steroid (.BNS) , 
of· 
represents th.e amount of tri tiated steroid bound i1n the 
presence of a 200-fold excess of radioinert competitor. 
I 
Total radioactive steroid (Tl ~as estimated by diJect 
sampling of incubates prior to the· addition of the 
I 
hydroxylapatite slurry. The quantities of BT' BNS' and 
I 
·T w~r~ determined by scintilla~ion counting while/ 
s,pecifically bound steroid (B 8 J: was estimated by 
' 
. ,.-.~..':·• 
subtracting BNS from BT, and total free steroid (F) was . I 
estimated by subtractiny BT from T. Specifically bound 
. I 
steroid.(85 ), as. the x-variable, was·plptted against the 
bound to free ratio (B5/F) as the y-variable.(Figu~e 2). 
A line was fitted to the dat~ points by least squ~res 
t't~<Jri>ssion ~nalysis and'Brnax and Kd were estimated as 
the x-intercept and - l/slope, respectively. B : and max 
K<l were calculated.in terms of count rates tdisintegra-
tions per minute, dpm) and then converted to molar . ' 
concentrations. Estimated binding sites (the molar 
equivalent.of Bmax) were standardized by protein 
tration, as determined by the ·r1ethod of Lowry ~!: 
concen-
i 1 (30), 
_I_ 
with bovine ~er~m albumin (1 mg/ml) as standard. I The 
' I 
data were expressed as femp.tomoles· of bound stero:td per 
! 
milligram of protein (fmol/mg) for estimated bind~ng 
sites and moles per liter (M) for Kd. 
Table 1. Representa"tive Titration Data (Cyto~olic 3H Estradiol .Binding, · 
Tumor Nuinber 5) ·In Disintegrations Per Minute· (dpm). 
BT= total hound, BNS =non-specifically bound, Bs =specifically 
bound (BT - BNS = Bs), T = total radioactive st.eroid added, and 
F =total free steroid (T - BT= F). 
BT BNS B T F B /F 
3H Estradiol Concentration s s 
66,139 54,691 11,44,8 6 5 6,, 3 0 0 590,161 . 019 10.0 nf.1 
30,535 19,115 11,420 189,811 159,276 .072 3.0 nM 
11,529 3,819 7,710 45,500 3·3 '971 .22'7 . 5 nM 




Tahle ~- Estrogen Receptor (ER) Distribution and 






















( B) 0 
3 ( 6 0%) 
· (C) 1 (33%) 










'Progesterone Receptor .(PR) Distribution and 




















































Table ·G. Distribution and Respqnse 
Estrogen and Progesterone 
I 
I To Oophorectomy,. 
Receptor Status 



































(B) l . (100%) 
1 (5Q%) 
1 (100%) 
( D) 1 (33%) 
0 
I Number of 



















~ ... ~l ... ·· 
·:v;'' 
23 
independent in vivo. Also, one tumor which was negarive 
tor progesterone receptors, both cytosolic and nuc1Ja;, 
(A, table 5) and one tumor which was negative for nJclear 
estrogen receptor and cytosolic progesterone receptJr, 
I . ·' 
(D, table 5) were hormone-dependent in vivo. Leung 1et al, 
' 
( 31) has shown that prolactin can· stimulate estroge'n. 
! 
receptor in mammary tumors, and it is unknown whether 
I 
progestin receptprs are depen~ent on estrogen actiod 
directly or estrogen induced prolactin secretion (3?). 
! 
The presence of prolactin binding in the absence ofiestrogen 
binding can be associated with autonomous growth 
Prolactin dependence may explain the presence of 
(7). 
I 
ERJ and .PR 
in these "hormone-independent" tumors, and conversely,. 
' 
sensitivity to alterations in prolactin concentration may be 
I 
responsible f_or regression of the two tumors with minimal 
estrogen and progesterone receptor populations. ·Th1e same 
I 
model of prolactin dependence can account. for the rjegression 
of tumors which are steroid receptor negative and t!he 
I 
continued •growth of steroid r.eceptor positive tumors 
I 
following oophorectomy. 1 
Me_an receptor concentration was higher for bJth 
1 • 
I 
hormones in both locations, cytosol and nuclear extract, 
- - I 
in the hormone dependent group (table 7). Differences 
between groups did not attain statistical ~ignificlnce. 
Inspection of the binding data indicates that mea_n binding· 
.. 
rable 7. ·Average Receptbr Concentration Expressed As Femptomoles Per Milligram 






. 3H estradiol-17 
cytosol 
23.6 + 28.6 
12.2 + 9.0 
17.9 + 20.6 
nuclear 
+ 24.7 32.5 
8.1 + 14.7 
16.4 + 24.9 
3H 
cytosol 
267.0 + 403.7 
56.8 + 71.0 
161.9 + 290.9 
R5020 
nuclear 
139.1 + 223.7 
36.2 :1::. 43.2 
87.7 + 158.9 
I 
25 
site concentrations in tJ:ie hormone dependent group' are 
I 
shifted upward by the presence in each hormone rec'eptor 
locat i~n of one tumor with a .binding capacity seve/ra 1 . . . . I 
fold larger than the rest, (A,B,C,D; Table 2 . Tne 
observation that very high ·bindin.g capacity in eadh case 
' ' 
is associated with hormone independence is particularly 
' 
interesting in light of the suggestion by several: .. 
investigators that hormone dependency among bl'.'.easi: 











Normal breast tissue contains specific bindin~ sites 
. I 
its growth or 
. ! 
cells; may 
for each of the hormones known to influence 
development. With malignant transformation, 
I 
retain all or only part of" the normal population of 
receptor sites. If a cell retains receptors, it r~mains 
at least potentially capable bf.being regulated b~ the 
i 
hormonal environment. If receptor s'ites are lost •I the 
cell may escape from endocrin~ Control. 
The results of this investigation suggest a c;orre-
1 
lation between increasing estrogen and· progesterone 
receptor populations in the qualitative sense and' 
increasing numbers of regressions in response to 
oophorectomy, and perhaps a .quantitative relation•hip 
between steroid receptor concentration and hormone-
. . . 'f . 
dependence in vivo. -·-- The relationship between int~r-
mediate receptor popul?ttions and interme.diate 
' ' 





for evaluation of binding parameters for other hormones 
' 
influencing brea~t growth and function, particula~ly 
. .· I 
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